Cargando…
Monodisperse polysarcosine-based highly-loaded antibody-drug conjugates
Antibody-drug conjugates (ADCs) convey highly potent anticancer drugs to antigen-expressing tumor cells, thereby sparing healthy tissues throughout the body. Pharmacokinetics and tolerability of ADCs are predominantly influenced by the drug-antibody ratio (DAR) of the conjugates, which is to-date li...
Autores principales: | Viricel, Warren, Fournet, Guy, Beaumel, Sabine, Perrial, Emeline, Papot, Sébastien, Dumontet, Charles, Joseph, Benoît |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457330/ https://www.ncbi.nlm.nih.gov/pubmed/31015945 http://dx.doi.org/10.1039/c9sc00285e |
Ejemplares similares
-
Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform
por: Conilh, Louise, et al.
Publicado: (2021) -
Payload diversification: a key step in the development of antibody–drug conjugates
por: Conilh, Louise, et al.
Publicado: (2023) -
Automated linkage of proteins and payloads producing monodisperse conjugates
por: Dovgan, Igor, et al.
Publicado: (2020) -
Efficient Shielding of Polyplexes Using Heterotelechelic Polysarcosines
por: Klein, Philipp Michael, et al.
Publicado: (2018) -
Polysarcosine-Functionalized mRNA Lipid Nanoparticles Tailored for Immunotherapy
por: Wilhelmy, Christoph, et al.
Publicado: (2023)